Business Context and Reporting Period
Company: Ultralife Batteries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 28, 2002 (First Quarter of Fiscal 2003)
Business Overview: The company develops, manufactures, and markets standard and customized lithium primary (non-rechargeable) and rechargeable batteries for industrial, military, and consumer applications. Operations are reported in four segments: Primary Batteries, Rechargeable Batteries, Technology Contracts, and Corporate.
Key Financial Metrics
| Metric (in thousands) | Q1 2003 (Ended Sep 28) | Q1 2002 (Ended Sep 30) |
|---|---|---|
| Revenues | $6,847 | $7,616 |
| Gross Margin | $129 | $(448) |
| Gross Margin % | 2% | (6%) |
| Operating Loss | $(1,917) | $(3,751) |
| Net Loss | $(1,778) | $(3,642) |
| Net Loss Per Share (Basic/Diluted) | $(0.14) | $(0.30) |
| Cash and Cash Equivalents | $929 | $1,196 |
| Total Debt (Current + Long-term) | $2,944 | N/A |
| Net Cash Used in Operating Activities | $(945) | $(4,027) |
Note: Debt figures for Q1 2002 are not explicitly aggregated in the provided text, though Q1 2003 total debt is $2,944 ($2,841 current + $103 long-term).
Material Changes vs. Prior Period
- Revenue Decline: Consolidated revenues decreased 10% to $6.8 million. Primary battery sales dropped 8% due to lower 9-volt shipments and reduced military orders. Technology contract revenues fell $207,000 due to the completion of non-renewable government contracts.
- Gross Margin Improvement: The company moved from a gross margin loss of $448,000 in the prior year to a profit of $129,000. This $577,000 improvement was driven by cost-saving actions and lower depreciation expenses following a write-down of rechargeable fixed assets in the prior fiscal year.
- Expense Reduction: Total operating expenses decreased 38% to $2.0 million. Research and development expenses fell $705,000, and selling, general, and administrative (SG&A) expenses declined $552,000, largely due to revised strategies and cost-cutting initiatives.
- Net Loss Reduction: Net loss improved significantly to $1.8 million from $3.6 million in the prior year, primarily due to the reduction in operating expenses and improved gross margins.
Guidance, Outlook, and Risks
Outlook and Guidance
- Q2 Revenue Forecast: Management expects Q2 revenues to exceed $9.0 million, driven by strengthened 9-volt orders and growing interest in military batteries (specifically the BA-5390).
- Profitability Targets: Quarterly revenues of $9.0M–$9.5M are projected to achieve operating cash breakeven. Revenues of approximately $10.5M are needed to report a profit.
- Full Year Target: The company maintains a target of 35% revenue growth for the full fiscal year 2003, though Q1 results were lower than initial projections.
Liquidity and Capital Resources
The company faces serious liquidity concerns. Cash and cash equivalents totaled $929,000, with $201,000 restricted. The company utilized $945,000 in cash for operations. It has a $15 million credit facility expiring in June 2003, with $2.2 million outstanding and approximately $500,000 remaining borrowing capacity. Management is working to extend this facility but notes no assurance of success. Alternative funding sources, including asset sales or equity financing, are being evaluated.
Risks and Contingencies
- Legal Proceedings: A shareholder class action lawsuit regarding a 1998 stock offering is pending settlement approval. The company has reserved $175,000 for its share of the settlement, but the insurance carrier covering the settlement has entered liquidation proceedings, creating uncertainty regarding funding.
- Environmental Liability: Contaminated soil was discovered at the Newark, NY facility. Estimated remediation costs are $230,000, with a third party agreeing to reimburse 50%. The company has reserved for its portion, but final costs are uncertain.
- Product Warranty Claim: A customer's end-user has claimed a product powered by an Ultralife battery failed to meet specifications. While no claim has been filed against Ultralife, the company agreed to provide technical support and honor warranties, which could have a material adverse effect if the product is deemed defective.
- Subsequent Event: On October 23, 2002, the company exchanged shares in its Taiwan venture (UTI) for $2.4 million in cash and the return of 700,000 common shares. This transaction is expected to generate a non-operating gain of at least $2.4 million in Q2 and reduce outstanding shares to 12,652,269.
Investor Verification Checklist
- Liquidity Runway: Verify the company's ability to secure an extension of its credit facility expiring in June 2003 or raise alternative capital to meet working capital needs.
- Settlement Funding: Confirm the status of the shareholder lawsuit settlement and whether the company must fund the $175,000 reserve due to the insurance carrier's liquidation.
- Revenue Mix: Monitor the mix of primary vs. rechargeable battery sales, as the rechargeable segment continues to operate at a loss and impacts overall margins.
- Subsequent Event Impact: Verify the receipt of the $2.4 million cash proceeds from the UTI share exchange and the recording of the associated gain in the next quarter.
- Environmental Costs: Track the approval of the remediation plan for the Newark facility to ensure actual costs do not exceed the reserved amount.